Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective

نویسندگان

  • Christopher P. Austin
  • Christine M. Cutillo
  • Lilian P.L. Lau
  • Anneliene H. Jonker
  • Ana Rath
  • Daria Julkowska
  • David Thomson
  • Sharon F. Terry
  • Béatrice de Montleau
  • Diego Ardigò
  • Virginie Hivert
  • Kym M. Boycott
  • Gareth Baynam
  • Petra Kaufmann
  • Domenica Taruscio
  • Hanns Lochmüller
  • Makoto Suematsu
  • Carlo Incerti
  • Ruxandra Draghia‐Akli
  • Irene Norstedt
  • Lu Wang
  • Hugh J.S. Dawkins
چکیده

Christopher P. Austin1,∗, Christine M. Cutillo1, Lilian P.L. Lau2, Anneliene H. Jonker2, Ana Rath2,3, Daria Julkowska4, David Thomson5, Sharon F. Terry6, Béatrice de Montleau7, Diego Ardigò8, Virginie Hivert7, Kym M. Boycott9, Gareth Baynam10,11, Petra Kaufmann1, Domenica Taruscio12, Hanns Lochmüller13, Makoto Suematsu14, Carlo Incerti15, Ruxandra Draghia-Akli16,17, Irene Norstedt16, Lu Wang18 and Hugh J.S. Dawkins19 on behalf of the International Rare Diseases Research Consortium (IRDiRC)

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review

Pheochromocytomas (PCCs) are rare neuroendocrine tumors. The current diagnostic tools are based on biochemistry and histopathology results, but heterogeneity of diagnostic markers, signs and symptoms of PCCs bring a lot of difficulties for these two current methods. Unfortunately microscopic understanding of PCCs is not adequate for its confident prognosis and management. There are data linking...

متن کامل

Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures

Our ability to evaluate outcomes which genuinely reflect patients' unmet needs, hopes and concerns is of pivotal importance. However, much current clinical research and practice falls short of this objective by selecting outcome measures which do not capture patient value to the fullest. In this Opinion, we discuss Patient-Centered Outcomes Measures (PCOMs), which have the potential to systemat...

متن کامل

Exosomes: Future Perspective in Neurodegenerative Diseases

Neurodegeneration is a progressive and irreversible loss of neuronal cells in specific regions of the brain. Alzheimer Diseases (AD) Parkinson Disease (PD) are the most common forms of neurodegenerative diseases in older people. Exosomes are extracellular nanovesicles that have a key role in physiological processes such as intercellular communication, cell migration, angiogenesis, and anti-tumo...

متن کامل

Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective

Rare diseases by definition are conditions that affect small numbers of people. The prevalence threshold that designates a disease as rare varies in different countries. Generally, diseases with prevalence fewer than 5 in 10,000 people are considered rare.1 Many rare diseases affect far fewer people worldwide, with some having a single identified case and others with cases numbering from tens t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 11  شماره 

صفحات  -

تاریخ انتشار 2018